Changeflow GovPing Healthcare & Life Sciences 14 Organizations Join USP Convention Including ...
Routine Notice Added Final

14 Organizations Join USP Convention Including African Medicines Agency, Egyptian Drug Authority

Favicon for www.usp.org USP News
Published
Detected
Email

Summary

USP added 14 organizations to its Convention as of Spring 2026, including the African Medicines Agency, Egyptian Drug Authority, Indonesian Food and Drug Authority, and Rwandan FDA, among others. The Convention now comprises over 450 member organizations from more than 50 countries representing science, manufacturing, regulatory, patient advocacy, government, and academia. Convention Members provide input and elect USP's Board of Trustees and Council of Experts, supporting USP's mission to protect and promote health by advancing quality across the lifecycle of medicines worldwide.

Published by USP on usp.org . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USP News for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 4 changes logged to date.

What changed

USP expanded its Convention membership by 14 organizations spanning regulatory agencies, pharmaceutical industry groups, patient advocacy organizations, and academic institutions across Africa, Asia, and North America. The Convention serves as one of USP's governing bodies whose participation informs USP's work and elects its Board of Trustees and Council of Experts. This expansion affects organizations engaged with pharmaceutical quality standards, regulatory harmonization, and supply chain resilience — Convention Members gain a formal role in shaping USP's strategic direction and standard-setting priorities.

Affected parties include pharmaceutical manufacturers, regulatory authorities, healthcare practitioners, and patient advocacy organizations that participate in or rely on USP quality standards for medicines, dietary supplements, and food ingredients. The expanded membership broadens the diversity of perspectives informing USP's standard-setting processes but does not create new compliance obligations for regulated entities at this time.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

The USP Convention welcomes new Members

The 450+ Member organizations that make up the USP Convention provide a breadth of critical perspectives that help strengthen USP’s global impact

Rockville, MD - April 22, 2026 - The U.S. Pharmacopeia (USP) has added 14 Members to the USP Convention, expanding the breadth and depth of stakeholder perspectives that help guide and strengthen USP’s mission to improve people’s health.

The inclusion of these new Convention Members is a reflection of USP’s commitment to improving people's health around the world through public standards and solutions that help ensure the quality of medicines, supplements, and food ingredients. Convention Member participation helps USP respond to evolving needs across industry, regulatory, practitioner, patient and other communities, and affirms USP’s role as a trusted, private non-profit organization with a growing global presence.

“The USP Convention brings together a community of voices whose varied perspectives help inform how USP addresses real-world quality challenges and advocates for strengthening patient access to quality medicines,” said Anthony Lakavage, Secretary, USP Board of Trustees and Convention. “The addition of these Members reflects stronger engagement across regions and sectors in advancing quality, supporting a resilient medicines supply chain, and protecting people’s health.”

Convention Member additions

The following organizations have joined the USP Convention as of Spring 2026:

  • African Medicines Agency (AMA)
  • Agence Béninoise du Médicament et des autres Produits de Santé (ABRP)
  • Algeria National Agency for Pharmaceutical Products (ANPP)
  • Angels for Change
  • Canadian Generic Pharmaceutical Association (CGPA)
  • Duke-Margolis Center for Health Policy
  • Egyptian Drug Authority (EDA)
  • Indonesian Food and Drug Authority (BPOM)
  • Institute of Drug Quality Control – Ho Chi Minh City
  • International Pharmaceutical Students’ Federation (IPSF)
  • Medicines Control Authority of Zimbabwe (MCAZ)
  • Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMGMAN)
  • Rwanda Food and Drugs Authority (Rwanda FDA)
  • Union des Opérateurs Pharmaceutiques (UNOP) Download the complete list of USP’s 450+ Convention Members

About the USP Convention

The USP Convention is one of USP’s governing bodies, providing input and insights that strengthen USP’s work and impact around the world. Convention membership represents a broad cross-section of the global health ecosystem and includes 450+ member organizations from more than 50 countries, representing expert perspectives of science, manufacturing, regulatory, patient advocacy, government, and academia.

Through the USP Convention, Members elect the Board of Trustees and Council of Experts – USP's other two governing bodies – supporting USP’s mission to protect and promote health by advancing quality across the lifecycle of medicines worldwide.

For additional information, please contact: mediarelations@usp.org

About USP

USP is a private, non‑profit scientific organization that collaborates with stakeholders around the world to develop public quality standards and solutions that support quality across the development, manufacturing, and delivery of regulated health products; strengthen regulatory systems; enhance supply reliability; and support the adoption of innovation. Used in more than 150 countries, USP standards and solutions play a critical role in increasing the availability of quality medicines, dietary supplements, and food ingredients worldwide.

Get daily alerts for USP News

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USP.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USP
Published
April 22nd, 2026
Instrument
Notice
Branch
Independent
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Public health authorities
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Standard-setting participation Regulatory coordination Supply chain quality
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Public Health Healthcare Consumer Protection

Get alerts for this source

We'll email you when USP News publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!